Strategies to improve diversity, equity, and inclusion in clinical trials.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 34495551.
- Also identified by DOI 10.1002/cncr.33905 and PMC identifier 9293140.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is a growing need for diversity, equity, and inclusion (DEI) in cancer care, particularly with respect to equal access and accrual to clinical trials. This commentary describe steps taken to address disparities in the authors' own clinical practice and proposes actions at the patient, provider, community, and institution levels to improve DEI in clinical trials.
Medical subject headings
- Cultural Diversity